Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha (Q39385110)

11 September 2017

Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha (English)

1 reference

11 September 2017

hepatocellular carcinoma

1 reference

11

1 reference

11 September 2017

Shengjie Zhang

1

1 reference

11 September 2017

Tingting Jiang

2

1 reference

11 September 2017

Lifeng Feng

3

1 reference

11 September 2017

Jie Sun

4

1 reference

11 September 2017

Haiqi Lu

5

1 reference

11 September 2017

Qinchuan Wang

6

1 reference

11 September 2017

Min Pan

7

1 reference

11 September 2017

Dongsheng Huang

8

1 reference

11 September 2017

Xian Wang

9

1 reference

11 September 2017

Linbo Wang

10

1 reference

11 September 2017

6 March 2012

1 reference

Journal of Molecular Medicine

11 September 2017

1 reference

11 September 2017

90

1 reference

11 September 2017

9

1 reference

11 September 2017

1069-1077

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-012-0879-y

11 September 2017

0 references

cites work

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Yin yang 1 modulates taxane response in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

YY1's longer DNA-binding motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

The involvement of the transcription factor Yin Yang 1 in cancer development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Reduced expression of C/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0879-Y

Transcription factor YY1 expression in human gastrointestinal cancer cells.

21 January 2018

1 reference

12 December 2020

Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation

1 reference

12 December 2020

A microRNA contribution to aberrant Ras activation in gastric cancer

1 reference

12 December 2020

CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma

1 reference

12 December 2020

EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.

1 reference

12 December 2020

C/EBPalpha: a tumour suppressor in multiple tissues?

1 reference

12 December 2020

Expression of transcription factor Yin Yang 1 in prostate cancer

1 reference

12 December 2020

Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

1 reference

12 December 2020

10.1007/S00109-012-0879-Y

Identifiers

DOI

1 reference

11 September 2017

1 reference